Cytogenetics and Molecular Biology of Osteosarcoma
- 1 April 2002
- journal article
- case report
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (4) , 365-373
- https://doi.org/10.1038/labinvest.3780431
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Molecular Pathology and Molecular Pharmacology of OsteosarcomaPediatric Pathology & Molecular Medicine, 2000
- Alterations in the RB, p16, and Cyclin D1 Cell Cycle Control Pathway in OsteosarcomasPediatric Pathology & Molecular Medicine, 2000
- Cytogenetic Findings in 36 Osteosarcoma Specimens and a Review of the LiteraturePediatric Pathology & Molecular Medicine, 2000
- DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcomaInternational Journal of Cancer, 1999
- Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcomaJournal of Surgical Oncology, 1998
- Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in OsteosarcomasJapanese Journal of Cancer Research, 1998
- Alterations of thep53, Rb andMDM2 genes in osteosarcomsZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Clinical Importance of near-Diploid Tumor Stem Lines in Patients with Osteosarcoma of an ExtremityNew England Journal of Medicine, 1988
- Pleiotropic effects of the gene for retinoblastomaJournal of Medical Genetics, 1974
- OsteosarcomaActa Radiologica, 1961